Our blog

A long-term partnership built on trust and industry insight enabled our Life Science recruitment team to deliver exceptional results for a global biotech leader, helping them expand their European sales team with speed, precision, and cultural alignment.

June 2025 delivered major developments across the life science industry - from headline-grabbing acquisitions and AI-driven drug discovery partnerships to multi-million-dollar funding rounds and product innovations in diagnostics, genomics, and precision medicine.

Head-hunter Katie Davis is consistently keeping up to date with the latest news within the biotech industry. From funding to collaborations, acquisitions, product and legal updates, in this blog we explore the latest funding updates throughout the month of May.

Head-hunter Katie Davis is consistently keeping up to date with the latest news within the biotech industry. In this blog, we explore the latest funding updates throughout the month of March.

Head-hunter Katie Davis is consistently keeping up to date with the latest news within the biotech industry. In this blog, we explore the latest funding updates throughout Q4 2024.

Head-hunter Katie Davis is consistently keeping up to date with the latest news within the biotech industry. In this blog, we explore the latest funding updates throughout the month of February.

Hiring the right talent is crucial to success. As a recruitment company specializing in life science and medical executive search, we’ve seen first-hand how hiring mistakes can derail even the most promising companies. But where do these mistakes typically start?

Head-hunter Katie Davis is consistently keeping up to date with the latest news within the biotech industry, whether that be funding news, acquisitions, spin outs and expansions, legal updates, layoffs and restructuring, collaborations or general product updates. In this blog, we explore the latest updates throughout the month of January.

Across the life sciences market, IPOs are more than just fundraising —they are indicators of investor confidence and market potential. After a slowdown in recent years, IPO activity is picking up pace again in 2025, particularly within biotech. In this blog, Katie Davis explores the latest trends.